Occurrence of neuroleptic malignant syndrome in a narcoleptic patient.
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D002389:Catatonia / Q000139:chemically induced* / Q000175:diagnosis; D003913:Dextroamphetamine / Q000009:adverse effects; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D009290:Narcolepsy / Q000188:drug therapy*; D010259:Paranoid Disorders / Q000139:chemically induced / Q000188:drug therapy; D011954:Receptors, Dopamine / Q000187:drug effects; D013577:Syndrome
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D003913:Dextroamphetamine